Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
It is important that the sterile filtration process is fully understood and properly validated for your particular application.
The process requirements and validation needs differ based on the filtration requirement. This webinar will give you a comprehensive understanding of this important subject with an emphasis on the different types of sterilizing filtration available and their application to your particular system.
For example, the application of sterile filtration to use-point compressed air is discussed in detail.
Why should you Attend: A review of the different filtration media is provided with the construction characteristics and properties of each detailed.
A detailed description of a typical pharmaceutical sterile filtration system with its individual components is provided. Engineering schematics are included. Microbiology and particle retention mechanisms are discussed.
Integrity testing methods are detailed as well as media qualification. Procedures for the sterilization of the filter are presented (SIP, autoclave, etc.).
The proper validation of sterile filtration is important to ensure that the filter will reproducibly remove undesirable components (bioburden) while allowing passage of desirable components (drug product). The operating parameters of time, pressure and temperature are fully discussed as well as the filters potential effect on the product (compatibility, leachables, fibers, endotoxin, etc.). Microbial retention challenge testing is one of the validation requirements.
Finally, a compilation of all FDA/EU GMP regulatory guidances concerning sterile filtration are presented. Related to this; the responsibilities of the filter manufacturer vs. the filter user is fully discussed.
Areas Covered in the Session: